Multifunctional host defense peptides: Antiparasitic activities

FEBS Journal

Volumn 276, Issue 22, 2009, Pages 6474-6482

  Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antimicrobial peptide; Chemical mimicry; Drug design; Drug resistance; Infectious disease; Leishmaniasis; Malaria; Membrane active compound; Oligo acyl lysyl; Peptide mimetic

Indexed keywords

ANTIPARASITIC AGENT; BOMBININ; CECROPIN; DEFENSIN; DROSOMYCIN; GRAMICIDIN S; MAGAININ 2; POLYPEPTIDE ANTIBIOTIC AGENT; TACHYPLESIN; TYROTHRICIN;

ANTIMICROBIAL ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; BIOASSAY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; DRUG SELECTIVITY; HOST; HOST RESISTANCE; IC 50; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MIMICRY; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTIPARASITIC AGENTS; LEISHMANIA; MODELS, BIOLOGICAL; PARASITIC SENSITIVITY TESTS; PEPTIDES; PLASMODIUM;

VERTEBRATA;

EID: 70350461828     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07358.x     Document Type: Short Survey

References (41)

1. Korenromp EL (2004) Malaria Incidence Estimates at Country Level for the Year 2004 - Proposed Estimates and Draft Report. Roll Back Malaria, World Health Organization, Geneva.
2. Bruce-Chwatt LJ (1982) Chemoprophylaxis of malaria in Africa: the spent 'magic bullet'. BMJ 285, 674 676.
3. Krishna S, Woodrow CJ, Staines HM, Haynes RK Mercereau-Puijalon O (2006) Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol Med 12, 200 205.
4. World Health Organization (2005) World Malaria Report 2005. WHO, Geneva. http://www.rbm.who.int/wmr2005.
5. Vizioli J Salzet M (2002) Antimicrobial peptides versus parasitic infections. Trends Parasitol 18, 475 476.
6. Gwadz RW, Kaslow D, Lee JY, Maloy WL, Zasloff M Miller LH (1989) Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect Immun 57, 2628 2633.
7. Boman HG, Wade D, Boman IA, Wahlin B Merrifield RB (1989) Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett 259, 103 106.
8. Tian C, Gao B, Rodriguez MC, Lanz-Mendoza H, Ma B Zhu S (2008) Gene expression, antiparasitic activity, and functional evolution of the drosomycin family. Mol Immunol 45, 3909 3916.
9. Conde R, Zamudio FZ, Rodriguez MH Possani LD (2000) Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett 471, 165 168.
10. Carballar-Lejarazu R, Rodriguez MH, de la Cruz Hernandez-Hernandez F, Ramos-Castaneda J, Possani LD, Zurita-Ortega M, Reynaud-Garza E, Hernandez-Rivas R, Loukeris T, Lycett G et al. (2008) Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens. Cell Mol Life Sci 65, 3081 3092.
11. Kulkarni MM, McMaster WR, Kamysz E, Kamysz W, Engman DM McGwire BS (2006) The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol 62, 1484 1497.
12. Tsuji N, Battsetseg B, Boldbaatar D, Miyoshi T, Xuan X, Oliver JH Jr. Fujisaki K (2007) Babesial vector tick defensin against Babesia sp. parasites. Infect Immun 75, 3633 3640.
13. Leitch GJ Ceballos C (2009) A role for antimicrobial peptides in intestinal microsporidiosis. Parasitology 136, 175 181.
14. Gelhaus C, Jacobs T, Andra J Leippe M (2008) The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum. Antimicrob Agents Chemother 52, 1713 1720.
15. Jacobs T, Bruhn H, Gaworski I, Fleischer B Leippe M (2003) NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrob Agents Chemother 47, 607 613.
16. Maciel C, de Oliveira VX Jr., Fazio MA, Nacif-Pimenta R, Miranda A, Pimenta PF Capurro ML (2008) Anti-plasmodium activity of angiotensin II and related synthetic peptides. PLoS ONE 3, e3296.
17. Mangoni ML, Papo N, Saugar JM, Barra D, Shai Y, Simmaco M Rivas L (2006) Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry 45, 4266 4276.
18. Mangoni ML, Saugar JM, Dellisanti M, Barra D, Simmaco M Rivas L (2005) Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem 280, 984 990.
19. Giacometti A, Cirioni O, Del Prete MS, Barchiesi F Scalise G (2000) Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture. Antimicrob Agents Chemother 44, 3473 3475.
20. Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Fineo A Scalise G (2001) Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. J Antimicrob Chemother 47, 97 99.
21. Lofgren SE, Miletti LC, Steindel M, Bachere E Barracco MA (2008) Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Exp Parasitol 118, 197 202.
22. Moreira CK, Rodrigues FG, Ghosh A, Varotti FP, Miranda A, Daffre S, Jacobs-Lorena M Moreira LA (2007) Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp Parasitol 116, 346 353.
23. Hu Y Aksoy S (2005) An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans. Insect Biochem Mol Biol 35, 105 115.
24. Mason AJ, Moussaoui W, Abdelrahman T, Boukhari A, Bertani P, Marquette A, Shooshtarizaheh P, Moulay G, Boehm N, Guerold B et al. (2009) Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. J Biol Chem 284, 119 133.
25. Rivas L, Luque-Ortega JR Andreu D (2008) Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim Biophys Acta 1788, 1570 1581.
26. Luque-Ortega JR, Vant HW, Veerman EC, Saugar JM Rivas L (2008) Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J 22, 1817 1828.
27. Rautenbach M, Vlok NM, Stander M Hoppe HC (2007) Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis. Biochim Biophys Acta 1768, 1488 1497.
28. Hernandez C, Mor A, Dagger F, Nicolas P, Hernandez A, Benedetti EL Dunia I (1992) Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin. Eur J Cell Biol 59, 414 424.
29. Ghosh JK, Shaool D, Guillaud P, Ciceron L, Mazier D, Kustanovich I, Shai Y Mor A (1997) Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J Biol Chem 272, 31609 31616.
30. Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H Mor A (2000) Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother 44, 2442 2451.
31. Dagan A, Efron L, Gaidukov L, Mor A Ginsburg H (2002) In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother 46, 1059 1066.
32. Efron L, Dagan A, Gaidukov L, Ginsburg H Mor A (2002) Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J Biol Chem 277, 24067 24072.
33. Scott RW, DeGrado WF Tew GN (2008) De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol 19, 620 627.
34. Rotem S Mor A (2008) Antimicrobial peptide mimics for improved therapeutic properties. Biochim Biophys Acta 1788, 1582 1592.
35. Radzishevsky I, Krugliak M, Ginsburg H Mor A (2007) Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob Agents Chemother 51, 1753 1759.
36. Soravia E, Martini G Zasloff M (1988) Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Lett 228, 337 340.
37. Madison MN, Kleshchenko YY, Nde PN, Simmons KJ, Lima MF Villalta F (2007) Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Infect Immun 75, 4780 4791.
38. Brand GD, Leite JR, Silva LP, Albuquerque S, Prates MV, Azevedo RB, Carregaro V, Silva JS, Sá VC, Brandão RA et al. (2002) Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J Biol Chem 277, 49332 49340.
39. Brand GD, Leite JR, de Sá Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH et al. (2006) Novel dermaseptins from Phyllomedusa hypochondrialis. Biochem Biophys Res Commun 347, 739 746.
40. Epand RM Epand RF (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788, 289 294.
41. Nicolas P (2009) Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides. FEBS J 276, doi :.